Verition Fund Management LLC Zynerba Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

  • $16.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.87 - $1.36 $9,224 - $14,420
-10,603 Reduced 34.56%
20,078 $15,000
Q2 2022

Aug 15, 2022
BUY
$0.86 - $2.06 $26,385 - $63,202
30,681 New
30,681 $35,000
Q3 2020

Nov 16, 2020
SELL
$3.23 - $4.3 $32,300 - $43,000
-10,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$3.31 - $6.54 $33,100 - $65,400
10,000 New
10,000 $34,000

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email